Expanding Medicare Advantage for patients with end-stage renal disease
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
This study looks at how letting people with end-stage kidney disease join Medicare Advantage plans can help them get better healthcare and improve their health, especially for those in underserved communities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10795031 on NIH RePORTER |
What this research studies
This research investigates the impact of allowing patients with end-stage renal disease (ESRD) to enroll in Medicare Advantage plans, which could improve their access to healthcare. It focuses on understanding how this policy change affects health outcomes, hospitalizations, and disparities in care among disadvantaged communities. The study will analyze data on ESRD patients to evaluate the effectiveness of these plans and their implications for health equity. By examining the experiences of patients who transition to these plans, the research aims to provide valuable insights for policymakers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with end-stage renal disease who are eligible for Medicare.
Not a fit: Patients who do not have end-stage renal disease or those who are not eligible for Medicare may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and outcomes for patients with end-stage renal disease.
How similar studies have performed: Previous research has shown that policy changes in Medicare coverage can significantly impact health outcomes for patients with chronic conditions, suggesting potential success for this approach.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Trivedi, Amal N. — Brown University
- Study coordinator: Trivedi, Amal N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.